Greater Washington had its second-biggest venture funding year in at least a decade in 2017, with startups across the metro area raking in more than $1.55 billion.
TAI Diagnostics said earlier this week that it had closed a $10 million round of funding and forged a new partnership with United Therapeutics (NASDAQ: UTHR).
Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of a Phase 2 dose ranging study to evaluate the safety, pharmacokinetics, and clinical benefit of FLU-IGIV, the company’s anti-influenza immune globulin being developed as an intravenous treatment for serious illness caused by influenza A infection in hospitalized patients.
In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a lot of it floating around the D.C. metro area. Here’s a roundup of all of the major funding news from the region in December:
Virginia Bio, the premier statewide non-profit association representing the life science industry in the Commonwealth of Virginia, has elected two new members to their Board of Directors for a term of three years. The election took place on December 14, 2017 at the Virginia Bio Annual Membership meeting in Richmond, Virginia. The new directors will begin their terms effective on January 1, 2018.
Venture capitalists poured $1.55 billion into D.C. area technology start-ups last year, an industry report found, as a handful of so-called megadeals propelled the region to a six-year high for technology investing in 2017.
Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, has raised $75 million to expand access to genomic testing for cancer patients.
NexImmune, an emerging leader in the field of antigen-directed immunotherapy, announced the closing of a Series A financing co-led by new investor ArrowMark Partners and existing investor Barer & Son Capital, along with significant participation from Piedmont Capital Partners. In conjunction with the financing, Tony Yao, MD, PhD, a Partner at ArrowMark Partners, will join NexImmune’s Board of Directors.
George Davis, CEO of the Maryland Technology Development Corporation (TEDCO), joins Rich Bendis to discuss the Economic Development Balance, Goals for Business in the State, and the Partnership across the Region.